CAM
SPRY icon

Cresset Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Cresset Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Hold
30,152
– – ﹤0.01% 1380
2025
Q4 		$351K Hold
30,152
– – ﹤0.01% 1224
2025
Q3 		$303K Hold
30,152
– – ﹤0.01% 1236
2025
Q2 		$526K Buy
30,152
+1,900
+7% +$27.4K ﹤0.01% 908
2025
Q1 		$355K Buy
28,252
+500
+2% +$6.02K ﹤0.01% 1233
2024
Q4 		$293K Buy
27,752
+3,270
+13% +$45.8K ﹤0.01% 1363
2024
Q3 		$355K Hold
24,482
– – ﹤0.01% 1719
2024
Q2 		$208K Buy
+24,482
New +$217K ﹤0.01% 1880

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return